Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Who is novosanis
Latest news
Eurogin 2019: An event to remember
19/12/2019
It's been a few weeks since we've been back from Eurogin 2019. Read our news item sharing a few highlights of our trip and the conference.
Latest blogpost
Upcoming event
IPVC 2020
Barcelona
Novosanis will be attending the 33rd International Papillomavirus Conference in Barcelona from March 23 to 27. IPVC 2020 will gather researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and its associated diseases.
Events
Regulatory
Team
News